Kestra Advisory Services, LLC Sorrento Therapeutics, Inc. Transaction History

Kestra Advisory Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$0.74 - $1.83 $29 - $73	-40 Reduced 0.22%	18,272 $16,000
Q3 2022 Nov 01, 2022	SELL	$1.51 - $2.88 $883 - $1,684	-585 Reduced 3.1%	18,312 $29 Million
Q2 2022 Aug 12, 2022	SELL	$1.24 - $2.33 $8,068 - $15,161	-6,507 Reduced 25.61%	18,897 $38,000
Q1 2022 Apr 26, 2022	BUY	$2.0 - $4.9 $12,150 - $29,767	6,075 Added 31.43%	25,404 $59,000
Q4 2021 Jan 20, 2022	SELL	$4.65 - $7.23 $12,373 - $19,239	-2,661 Reduced 12.1%	19,329 $89,000
Q3 2021 Oct 19, 2021	BUY	$7.41 - $10.99 $58,264 - $86,414	7,863 Added 55.66%	21,990 $167,000
Q2 2021 Jul 28, 2021	BUY	$6.35 - $10.0 $1,905 - $3,000	300 Added 2.17%	14,127 $136,000
Q1 2021 May 10, 2021	SELL	$7.03 - $16.51 $29,933 - $70,299	-4,258 Reduced 23.54%	13,827 $114,000
Q4 2020 Jan 20, 2021	BUY	$5.76 - $11.95 $104,169 - $216,115	18,085 New	18,085 $131 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.